Mesoblast limited (OTCMKTS:MBLTY) received a $14.00 price target from Maxim Group in a report issued on Thursday. The brokerage presently has a a “buy” rating on the stock. Maxim Group’s target price suggests a potential upside of 13.54% from the company’s previous close.

A number of other research analysts have also commented on MBLTY. Credit Suisse Group AG lowered Mesoblast limited to a “hold” rating in a research report on Wednesday, June 15th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Mesoblast limited in a research report on Wednesday, June 15th.

Shares of Mesoblast limited (OTCMKTS:MBLTY) remained flat at $12.33 during midday trading on Thursday. Mesoblast limited has a 12 month low of $10.27 and a 12 month high of $19.00. The company’s 50-day moving average is $12.26 and its 200-day moving average is $13.71.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

About Mesoblast limited

Receive News & Ratings for Mesoblast limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast limited and related companies with's FREE daily email newsletter.